Advertisement

Spinal Tech

Smith & Nephew CEO Olivier Bohuon is now publicly allaying rumors the company may consider a merger or sale to another medtech giant in the near future, according to a report from The Telegraph.

Mainstay Medical has received authorization from the Medicines and Healthcare Products Regulatory Agency and the Central Ethics Committee to expand the clinical trial of ReActiv8 to include clinical trial sites in the United Kingdom.

Advertisement
Advertisement